Ligandrol (LG-4033) 10mg
Category: SARMs
Active Ingredient: LG-4033
Packaging: 50 tablets x 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 24 to 36 hours
Commonly Abused Dose: 10 to 20 mg daily
There are 66 products.
Active filters
Category: SARMs
Active Ingredient: LG-4033
Packaging: 50 tablets x 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 24 to 36 hours
Commonly Abused Dose: 10 to 20 mg daily
Category: SARMs
Active Ingredient: MK-2866
Packaging: 50 tablets x 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 24 hours
Commonly Abused Dose: 15 to 30 mg daily
Category: SARMs
Active Ingredient: S-23
Packaging: 50 tablets x 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 12 hours in animals, unknown in humans
Commonly Abused Dose: 10 to 30 mg daily
Category: Injectable Substances (Peptide Hormone)
Active Ingredient: Thymosin Beta 4
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 3.5 to 7 hours
Dosage: Taken at a dose of 2.5 to 6 mg per week, with the dose divided into 2 to 3 doses per week
Category: SARMs
Active Ingredient: RAD-140
Packaging: 50 tablets x 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 15 to 20 hours
Commonly Abused Dose: most often 10 to 30 mg daily
Category: Injectable Substances (GLP-1 Receptor Agonist, weight-loss medication)
Active Ingredient: Semaglutide
Packaging: Vial containing 4 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 7 days
Dosage: Most commonly 0.5 to 1 mg weekly (from 0.25 to 1 mg weekly)
Category: Hybrid Myostatin Inhibitor
Active Ingredient: YK-11
Packaging: 50 tablets x 5 mg
Manufacturer: General Pharmaceuticals
Half-life: unknown
Commonly Abused Dose: 10 to 30 mg daily
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)
Category: Oral compounds (prolactin inhibitor)
Active ingredient: Cabergoline
Packaging: 30 tablets x 0.5 mg
Manufacturer: General Pharmaceuticals
Half-life: 2 to 3 days
Common misuse dosage: 0.25 to 0.5 mg 1 to 2× weekly
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)
Category: Oral compounds (prolactin inhibitor)
Active ingredient: Yohimbine Hydrochloride
Packaging: 50 x 5 mg
Manufacturer: General Pharmaceuticals
Half-life: 0.5 to 2.5 hours
Misused dose: 5 to 20 mg daily
Category: Synthetic peptide (GHRP)
Active ingredient: Ipamorelin
Packaging: 2 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 2 hours
Abused dose: 100 to 300 mcg daily